Trubridge Inc (TBRG)

$10.66

+0.39

(+3.8%)

Market is closed - opens 7 PM, 25 Jun 2024

Insights on Trubridge Inc

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 85.86M → 83.24M (in $), with an average decrease of 3.1% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -42.47M → -2.44M (in $), with an average increase of 1635.1% per quarter

Performance

  • $10.25
    $10.75
    $10.66
    downward going graph

    3.85%

    Downside

    Day's Volatility :4.65%

    Upside

    0.84%

    downward going graph
  • $7.55
    $26.73
    $10.66
    downward going graph

    29.17%

    Downside

    52 Weeks Volatility :71.75%

    Upside

    60.12%

    downward going graph

Returns

PeriodTrubridge IncIndex (Russel 2000)
3 Months
13.4%
0.0%
6 Months
38.98%
0.0%
1 Year
38.98%
0.0%
3 Years
38.98%
-24.2%

Highlights

Market Capitalization
157.7M
Book Value
$13.14
Earnings Per Share (EPS)
-0.05
PEG Ratio
0.88
Wall Street Target Price
13.8
Profit Margin
-15.27%
Operating Margin TTM
2.87%
Return On Assets TTM
-1.37%
Return On Equity TTM
-24.57%
Revenue TTM
336.4M
Revenue Per Share TTM
23.67
Quarterly Revenue Growth YOY
-3.5000000000000004%
Gross Profit TTM
154.4M
EBITDA
8.0M
Diluted Eps TTM
-0.05
Quarterly Earnings Growth YOY
-0.62
EPS Estimate Current Year
1.14
EPS Estimate Next Year
1.53
EPS Estimate Current Quarter
0.15
EPS Estimate Next Quarter
0.2

Analyst Recommendation

Buy
    63%Buy
    36%Hold
    0
    0%Sell
Based on 11 Wall street analysts offering stock ratings for Trubridge Inc(by analysts ranked 0 to 5 stars)
Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
6
Hold
4
4
4
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 29.46%

Current $10.66
Target $13.80

Company Financials

FY18Y/Y Change
Revenue
280.4M
↑ 1.26%
Net Income
17.6M
↓ 201.24%
Net Profit Margin
6.29%
↑ 12.58%
FY19Y/Y Change
Revenue
274.6M
↓ 2.06%
Net Income
19.7M
↑ 11.75%
Net Profit Margin
7.17%
↑ 0.88%
FY20Y/Y Change
Revenue
264.5M
↓ 3.69%
Net Income
14.2M
↓ 27.7%
Net Profit Margin
5.39%
↓ 1.78%
FY21Y/Y Change
Revenue
280.6M
↑ 6.1%
Net Income
18.4M
↑ 29.37%
Net Profit Margin
6.57%
↑ 1.18%
FY22Y/Y Change
Revenue
326.6M
↑ 16.4%
Net Income
15.9M
↓ 13.91%
Net Profit Margin
4.86%
↓ 1.71%
FY23Y/Y Change
Revenue
339.4M
↑ 3.91%
Net Income
-45.8M
↓ 388.58%
Net Profit Margin
-13.49%
↓ 18.35%
Q4 FY22Q/Q Change
Revenue
49.1M
↓ 40.69%
Net Income
2.5M
↑ 16.42%
Net Profit Margin
5.02%
↑ 2.46%
Q1 FY23Q/Q Change
Revenue
86.2M
↑ 75.54%
Net Income
3.1M
↑ 25.01%
Net Profit Margin
3.58%
↓ 1.44%
Q2 FY23Q/Q Change
Revenue
84.6M
↓ 1.87%
Net Income
-2.8M
↓ 191.99%
Net Profit Margin
-3.35%
↓ 6.93%
Q3 FY23Q/Q Change
Revenue
82.7M
↓ 2.26%
Net Income
-3.6M
↑ 25.56%
Net Profit Margin
-4.31%
↓ 0.96%
Q4 FY23Q/Q Change
Revenue
85.9M
↑ 3.82%
Net Income
-42.5M
↑ 1092.42%
Net Profit Margin
-49.46%
↓ 45.15%
Q1 FY24Q/Q Change
Revenue
83.2M
↓ 3.05%
Net Income
-2.4M
↓ 94.24%
Net Profit Margin
-2.94%
↑ 46.52%
FY18Y/Y Change
Total Assets
327.7M
↑ 2.99%
Total Liabilities
168.0M
↓ 7.78%
FY19Y/Y Change
Total Assets
356.0M
↑ 8.63%
Total Liabilities
171.7M
↑ 2.21%
FY20Y/Y Change
Total Assets
326.3M
↓ 8.36%
Total Liabilities
126.3M
↓ 26.45%
FY21Y/Y Change
Total Assets
383.4M
↑ 17.49%
Total Liabilities
160.8M
↑ 27.33%
FY22Y/Y Change
Total Assets
431.0M
↑ 12.42%
Total Liabilities
199.3M
↑ 23.93%
FY23Y/Y Change
Total Assets
434.4M
↑ 0.8%
Total Liabilities
247.8M
↑ 24.37%
Q4 FY22Q/Q Change
Total Assets
450.8M
↑ 2.93%
Total Liabilities
219.1M
↑ 6.86%
Q1 FY23Q/Q Change
Total Assets
436.8M
↓ 3.1%
Total Liabilities
203.3M
↓ 7.22%
Q2 FY23Q/Q Change
Total Assets
434.8M
↓ 0.48%
Total Liabilities
204.2M
↑ 0.46%
Q3 FY23Q/Q Change
Total Assets
429.5M
↓ 1.2%
Total Liabilities
201.5M
↓ 1.31%
Q4 FY23Q/Q Change
Total Assets
434.4M
↑ 1.14%
Total Liabilities
247.8M
↑ 22.95%
Q1 FY24Q/Q Change
Total Assets
416.4M
↓ 4.14%
Total Liabilities
231.7M
↓ 6.48%
FY18Y/Y Change
Operating Cash Flow
23.9M
↑ 1.21%
Investing Cash Flow
-978.0K
↑ 34.71%
Financing Cash Flow
-17.7M
↓ 27.94%
FY19Y/Y Change
Operating Cash Flow
43.6M
↑ 82.21%
Investing Cash Flow
-12.5M
↑ 1177.4%
Financing Cash Flow
-29.5M
↑ 66.21%
FY20Y/Y Change
Operating Cash Flow
49.1M
↑ 12.71%
Investing Cash Flow
-6.7M
↓ 46.66%
Financing Cash Flow
-37.2M
↑ 26.05%
FY21Y/Y Change
Operating Cash Flow
47.7M
↓ 2.84%
Investing Cash Flow
-69.9M
↑ 949.2%
Financing Cash Flow
20.9M
↓ 156.33%
FY22Y/Y Change
Operating Cash Flow
32.4M
↓ 32.19%
Investing Cash Flow
-62.7M
↓ 10.28%
Financing Cash Flow
25.9M
↑ 23.6%
Q4 FY22Q/Q Change
Operating Cash Flow
2.2M
↓ 80.52%
Investing Cash Flow
-4.3M
↓ 25.52%
Financing Cash Flow
-6.5M
↑ 32.62%
Q1 FY23Q/Q Change
Operating Cash Flow
9.5M
↑ 337.75%
Investing Cash Flow
-6.2M
↑ 45.09%
Financing Cash Flow
-3.4M
↓ 48.04%
Q2 FY23Q/Q Change
Operating Cash Flow
717.0K
↓ 92.43%
Investing Cash Flow
-6.0M
↓ 4.53%
Financing Cash Flow
5.7M
↓ 269.07%

Technicals Summary

Sell

Neutral

Buy

Trubridge Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Trubridge Inc
Trubridge Inc
9.22%
38.98%
38.98%
38.98%
2.6%
Solventum Corp
Solventum Corp
-14.3%
-25.76%
-25.76%
-25.76%
-25.76%
Veeva Systems Inc.
Veeva Systems Inc.
-8.07%
-1.77%
-6.34%
-40.24%
18.8%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
0.13%
0.91%
1.35%
30.35%
30.35%
Healthequity Inc
Healthequity Inc
4.46%
25.14%
38.61%
-0.74%
27.87%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Trubridge Inc
Trubridge Inc
NA
NA
0.88
1.14
-0.25
-0.01
NA
13.14
Solventum Corp
Solventum Corp
NA
NA
NA
6.26
0.17
0.08
NA
NA
Veeva Systems Inc.
Veeva Systems Inc.
54.7
54.7
1.35
4.76
0.13
0.06
NA
30.25
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
23.01
23.01
20.11
4.28
0.22
0.06
0.0
16.23
Healthequity Inc
Healthequity Inc
91.13
91.13
2.29
2.19
0.04
0.03
NA
24.11
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Trubridge Inc
Trubridge Inc
Buy
$157.7M
2.6%
NA
-15.27%
Solventum Corp
Solventum Corp
Hold
$10.8B
-25.76%
NA
15.73%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$29.9B
18.8%
54.7
22.34%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$36.1B
30.35%
23.01
8.05%
Healthequity Inc
Healthequity Inc
Buy
$7.3B
27.87%
91.13
7.71%

Institutional Holdings

  • BlackRock Inc

    7.10%
  • Vanguard Group Inc

    5.44%
  • Cove Street Capital, LLC

    4.90%
  • Hotchkis & Wiley Capital Management LLC

    3.40%
  • Ameriprise Financial Inc

    3.33%
  • Acadian Asset Management LLC

    3.05%

Company Information

cpsi is the leading provider of ehr systems to rural, community, and critical access hospitals. the cpsi ehr system provides complete integration of patient data across the healthcare delivery system resulting in improved care delivery and better patient outcomes.

Organization
Trubridge Inc
Employees
3219
CEO
Mr. Christopher L. Fowler
Industry
Finance

FAQs